6161 |
8EUV |
KL_F |
VRC34.01-COMBO1 Fab |
HIV-1 BG505 DS-SOSIP spike glycoprotein - gp41 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
2.6 | 10.1038/s41467-023-42098-5 |
6162 |
8EUV |
GH_B |
VRC34.01-COMBO1 Fab |
HIV-1 BG505 DS-SOSIP spike glycoprotein - gp41 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
2.6 | 10.1038/s41467-023-42098-5 |
6163 |
8EUW |
IJ_D |
VRC34.01-MM28 Fab |
HIV-1 BG505 DS-SOSIP spike glycoprotein - gp41 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
2.7 | 10.1038/s41467-023-42098-5 |
6164 |
8EUW |
KL_F |
VRC34.01-MM28 Fab |
HIV-1 BG505 DS-SOSIP spike glycoprotein - gp41 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
2.7 | 10.1038/s41467-023-42098-5 |
6165 |
8EUW |
GH_B |
VRC34.01-MM28 Fab |
HIV-1 BG505 DS-SOSIP spike glycoprotein - gp41 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
2.7 | 10.1038/s41467-023-42098-5 |
6166 |
8EW6 |
V_W |
Anti-human CD8 VHH |
Human T-cell surface glycoprotein CD8 alpha chain |
Homo sapiens, Lama glama |
XRD |
1.9 | 10.1007/s00259-022-05998-0 |
6167 |
8EZ3 |
HL_A |
3A10 Fab |
Influenza A virus Moscow/10/1999 H3N2 hemagglutinin |
Homo sapiens, Influenza A virus (A/Moscow/10/1999(H3N2)) |
EM |
2.5 | 10.1016/j.immuni.2023.10.005 |
6168 |
8EZ7 |
HL_A |
1F04 Fab |
Influenza A virus Moscow/10/1999 H3N2 hemagglutinin |
Homo sapiens, Influenza A virus (A/Moscow/10/1999(H3N2)) |
EM |
2.6 | 10.1016/j.immuni.2023.10.005 |
6169 |
8EZ8 |
HL_A |
3C08 Fab |
Influenza A virus Moscow/10/1999 H3N2 hemagglutinin |
Homo sapiens, Influenza A virus (A/Moscow/10/1999(H3N2)) |
EM |
2.78 | 10.1016/j.immuni.2023.10.005 |
6170 |
8EZK |
H_A |
AS01-04 scFv |
Plasmodium falciparum 25 kDa ookinete surface antigen |
Plasmodium falciparum, Homo sapiens |
XRD |
2.3 | 10.1038/s41541-023-00712-z |
6171 |
8EZK |
I_B |
AS01-04 scFv |
Plasmodium falciparum 25 kDa ookinete surface antigen |
Plasmodium falciparum, Homo sapiens |
XRD |
2.3 | 10.1038/s41541-023-00712-z |
6172 |
8EZL |
H_A |
AS01-50 scFv |
Plasmodium falciparum 25 kDa ookinete surface antigen |
Plasmodium falciparum |
XRD |
2.3 | 10.1038/s41541-023-00712-z |
6173 |
8EZM |
H_A |
AS01-63 scFv |
Plasmodium falciparum 25 kDa ookinete surface antigen |
Plasmodium falciparum, Homo sapiens |
XRD |
2.1 | 10.1038/s41541-023-00712-z |
6174 |
8F0G |
XY_C |
1C3 Fab |
SARS-CoV-2 Omicron BA.1 spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.35 | 10.1016/j.celrep.2023.112421 |
6175 |
8F0H |
BD_C |
1H2 Fab |
SARS-CoV-2 spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.18 | 10.1016/j.celrep.2023.112421 |
6176 |
8F0H |
HL_C |
2A10 Fab |
SARS-CoV-2 spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.18 | 10.1016/j.celrep.2023.112421 |
6177 |
8F0I |
CD_A |
COVA309-22 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.7 | 10.1016/j.isci.2023.108009 |
6178 |
8F0I |
EF_B |
COVA309-22 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.7 | 10.1016/j.isci.2023.108009 |
6179 |
8F0I |
HI_G |
COVA309-22 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.7 | 10.1016/j.isci.2023.108009 |
6180 |
8F5N |
HL_A |
E3 Fab |
Streptococcus pyogenes backbone pilins/T-antigens T18.1 N-domain |
Streptococcus pyogenes, Homo sapiens |
XRD |
1.9 | 10.1080/21505594.2023.2180228 |